This federal Project Grant award of $723,676 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a research study on the long-term effects of electronic cigarettes (e-cigarettes) on brain health. The study will investigate the relationship between an objective biomarker of cigarette smoke exposure and measures of brain structure, function, and cognition among former smokers who have switched to e-cigarettes, compared to...
The National Institute on Drug Abuse (NIDA) awarded a $254,810 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Research Foundation for the State University of New York (RF SUNY). The grant's goal is to validate the use of a wrist-worn Fitbit device to accurately measure and assess e-cigarette use behaviors in real-time among young adults. The project will examine the validity of the e-cigarette use data collected by the Fitbit device compared to...
This Project Grant award of $3,257,011 from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will fund a randomized controlled trial to evaluate the effectiveness of switching to electronic nicotine delivery systems (ENDS) compared to nicotine replacement therapy (NRT) for promoting smoking abstinence among individuals enrolled in substance use disorder (SUD) treatment programs in South Carolina. The study aims to: 1) assess...
This $619,477 federal Project Grant awarded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program supports research to investigate the impact of electronic cigarette (e-cigarette) exposure, both direct and in-utero, on vascular function and cognitive decline. The research, conducted by the West Virginia University Research Corporation, aims to establish the dose-dependent effects of e-cigarette exposure on vascular dysfunction and...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs, provides $353,508 to Clemson University to conduct a 3-group randomized controlled trial examining the impact of electronic cigarette (EC) flavor and use patterns on harm reduction milestones (e.g., cigarette per day reduction, switching) among people with opioid use disorder on buprenorphine. The 5-year project aims to offer the principal...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $265,239 to the University of North Carolina at Chapel Hill to conduct research on the effects of vaping-induced oxidation on nicotine analogs, such as 6-methyl nicotine, used in e-cigarettes. The key objectives are to: 1) analyze the chemical composition and metabolism of 6-methyl nicotine and nicotinamide vaping devices before and after...
This Project Grant award of $320,000 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a smoking and vaping cessation treatment based on the drug candidate cytisine. The goal is to explore the feasibility of delivering cytisine through electronic vape administration (EVA) to help stabilize dopamine release and reduce nicotine self-administration in a mouse model of nicotine addiction. Key activities include...
This Project Grant award of $1,315,596.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to understand the effects of maternal exposure to electronic nicotine delivery system (ENDS) aerosols during pregnancy on addiction-related behaviors and neurocircuitry in offspring. The project, which runs from March 2025 to December 2029, will use animal models to examine the impacts of prenatal ENDS exposure on...
This Project Grant award from the National Institutes of Health's Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $549,555.45 to The Trustees of the University of Pennsylvania to investigate the exposure and respiratory health effects of chemical constituents from electronic cigarette (e-cigarette) use among young adults. The project aims to: 1) evaluate the relationship between e-cigarette use and exposure to metals and aldehydes, 2) assess...
The National Institutes of Health (NIH) Office of the Director awarded a $1,197,896 Project Grant under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) to the University of Oklahoma Health Sciences Center. The objective of this 5-year longitudinal study is to use traditional survey methods combined with ecological momentary assessment (EMA) to better understand the impact of electronic nicotine delivery system (ENDS) product characteristics on...